Rx-360 International Pharmaceutical Supply Chain Consortium
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2011 | 774,187 | 774,187 | 0 | 0.0 | 0% |
| 2012 | 1,316,749 | 1,316,749 | 0 | 0.0 | 0% |
| 2013 | 1,755,594 | 1,755,594 | 0 | 0.0 | 0% |
| 2014 | 1,577,224 | 1,458,480 | 118,744 | 1.0 | 0% |
| 2015 | 1,712,455 | 1,585,951 | 126,504 | 1.9 | 0% |
| 2016 | 602,154 | 721,453 | −119,299 | 3.5 | 18% |
| 2017 | 1,643,664 | 1,523,943 | 119,721 | 1.5 | 32% |
| 2018 | 1,927,037 | 1,843,250 | 83,787 | 0.7 | 24% |
| 2019 | 1,467,673 | 1,489,161 | −21,488 | 0.8 | 36% |
| 2020 | 1,803,758 | 1,555,010 | 248,748 | 2.7 | 35% |
| 2021 | 2,943,923 | 2,053,844 | 890,079 | 7.3 | 33% |
| 2022 | 3,588,442 | 2,988,163 | 600,279 | 7.4 | 34% |
| 2023 | 4,214,492 | 3,541,635 | 672,857 | 8.5 | 37% |
In its most recent public year (2023), this organization brought in $672,857 more than it spent. Its reserves stood at about 8.5 months of spending, up from 0 in 2011. Staff pay was 37% of spending.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Rx-360 International Pharmaceutical Supply Chain Consortium's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works